Cargando…

Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic

The aim of this study is the characterization and genomic tracing by phylogenetic analyses of 59 new SARS-CoV-2 Italian isolates obtained from patients attending clinical centres in North and Central Italy until the end of April 2020. All but one of the newly-characterized genomes belonged to the li...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Alessia, Bergna, Annalisa, Caucci, Sara, Clementi, Nicola, Vicenti, Ilaria, Dragoni, Filippo, Cattelan, Anna Maria, Menzo, Stefano, Pan, Angelo, Callegaro, Annapaola, Tagliabracci, Adriano, Caruso, Arnaldo, Caccuri, Francesca, Ronchiadin, Silvia, Balotta, Claudia, Zazzi, Maurizio, Vaccher, Emanuela, Clementi, Massimo, Galli, Massimo, Zehender, Gianguglielmo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472216/
https://www.ncbi.nlm.nih.gov/pubmed/32722343
http://dx.doi.org/10.3390/v12080798
Descripción
Sumario:The aim of this study is the characterization and genomic tracing by phylogenetic analyses of 59 new SARS-CoV-2 Italian isolates obtained from patients attending clinical centres in North and Central Italy until the end of April 2020. All but one of the newly-characterized genomes belonged to the lineage B.1, the most frequently identified in European countries, including Italy. Only a single sequence was found to belong to lineage B. A mean of 6 nucleotide substitutions per viral genome was observed, without significant differences between synonymous and non-synonymous mutations, indicating genetic drift as a major source for virus evolution. tMRCA estimation confirmed the probable origin of the epidemic between the end of January and the beginning of February with a rapid increase in the number of infections between the end of February and mid-March. Since early February, an effective reproduction number (R(e)) greater than 1 was estimated, which then increased reaching the peak of 2.3 in early March, confirming the circulation of the virus before the first COVID-19 cases were documented. Continuous use of state-of-the-art methods for molecular surveillance is warranted to trace virus circulation and evolution and inform effective prevention and containment of future SARS-CoV-2 outbreaks.